To further demonstrate that CPD-L1-AZA combination could boost anti-tumor immune response in tumor microenvironment, the population of tumor infiltration lymphocytes (TILs), including CD8+T cells, CD4+T cells, Tregs and macrophages in the tumor tissues of 4T1 tumor-bearing mice, was analyzed after treatment. The gene discussed is CD4; the disease is neoplasm.